Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research expertise keywords
- Immunodeficiency
- Vaccines
- Paediatric immunisation
- Meningococcal disease
- Otitis media
- Influenza
Fingerprint
Dive into the research topics where Peter Richmond is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Safety and immunogenicity of a primary series and booster dose of the meningococcal serogroup B-factor H binding protein vaccine (MenB-FHbp) in healthy children aged 1-9 years: two phase 2 randomised, controlled, observer-blinded studies
Marshall, H. S., Vesikari, T., Richmond, P. C., Wysocki, J., Szenborn, L., Beeslaar, J., Maguire, J. D., Balmer, P., O'Neill, R., Anderson, A. S., Pregaldien, J-L., Maansson, R., Jiang, H-Q. & Perez, J. L., Jan 2023, In: Lancet Infectious Diseases. 23, 1, p. 103-116 14 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Web of Science) -
4CMenB vaccine and its role in preventing transmission and inducing herd immunity
McMillan, M., Marshall, H. S. & Richmond, P., 2022, In: Expert Review of Vaccines. 21, 1, p. 103-114 12 p.Research output: Contribution to journal › Article › peer-review
-
A brief history of MECP2 duplication syndrome: 20-years of clinical understanding
Ta, D., Downs, J., Baynam, G., Wilson, A., Richmond, P. & Leonard, H., Dec 2022, In: Orphanet Journal of Rare Diseases. 17, 1, 131.Research output: Contribution to journal › Review article › peer-review
Open Access3 Citations (Web of Science) -
An Observational Study to Assess the Effectiveness of 4CMenB against Meningococcal Disease and Carriage and Gonorrhea in Adolescents in the Northern Territory, Australia—Study Protocol
Marshall, H. S., Andraweera, P. H., Ward, J., Kaldor, J., Andrews, R., Macartney, K., Richmond, P., Krause, V., Koehler, A., Whiley, D., Giles, L., Webby, R., D’antoine, H., Karnon, J., Baird, R., Lawrence, A., Petousis-Harris, H., Wals, P. D., Greenwood-Smith, B., Binks, M., & 1 others, Feb 2022, In: Vaccines. 10, 2, 309.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
A phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of catch-up vaccination regimens of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants, children, and adolescents (PNEU-PLAN)
for the V114-024 PNEU-PLAN study group, 19 Oct 2022, In: Vaccine. 40, 44, p. 6315-6325 11 p.Research output: Contribution to journal › Article › peer-review
Open Access
-
The Platform trial in COVID-19 Vaccine BOOsting (PICOBOO)
Richmond, P., McLeod, C., Flanagan, K., Plebanski, M., Snelling, T., Marshall, H., Blyth, C. & Dymock, M.
Medical Research Future Fund MRFF
1/01/22 → 31/12/26
Project: Research
-
Merck Investigator Studies Program - A cross-sectional observational study on the aetiology of recurrent acute otitis media in Western Australia in the PCV13-era: the WALACE study (Western Australian Aetiology of Acute and Chronic Ear Disease)
Kirkham, L., Richmond, P., Herbert, H., Vijayasekaran, S., Sim, G., Kuthubutheen, J., Swift, V. & Brennan-Jones, C.
Merck, Sharp & Dohme Australia
23/09/21 → 23/09/23
Project: Research
-
Round 8 - A bacterial therapy to prevent otitis media – preparing for first-in-human studies
Kirkham, L., Richmond, P., Fulurija, A., Seppanen, E. & Strickland, D.
Department of Health (Western Australia)
1/07/20 → 28/02/23
Project: Research
-
C2144 CTRA (sponsor USyd) related to NHMRC APP1158722
National Health & Medical Research Council NHMRC
1/04/20 → 31/12/23
Project: Research